PrimeauDanilewitzCrockfordKleinmanJutras-AswadBahji . Concurrent disorders: treatment of comorbid alcohol use disorder and major depressive disorder. Can J Psychiatry. 2026:7067437251409626. doi:10.1177/07067437251409626
2.
BahjiADanilewitzMSloanMTangVCrockfordD. Concerns regarding the recommendation against prescribing selective serotonin reuptake inhibitors in the Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder. CMAJ: Canadian Medical Association Journal = Journal de L'Association Medicale Canadienne. 2024;196(10):E346-e347. doi:10.1503/cmaj.149917-l
3.
WoodERehmJ. Addressing the risks of antidepressants among people with alcohol use disorders. CMAJ: Canadian Medical Association Journal = Journal de L'Association Medicale Canadienne. 2024;196(10):E349-e350. doi:10.1503/cmaj.150095-l
4.
GreenhalghT. How to read a paper: The basics of evidence-based medicine and healthcare. 6th ed. Wiley-Blackwell; 2019.
5.
BahjiATangVDanilewitzM. Integrated management of co-occurring alcohol use disorder and depression: clinical approaches for concurrent disorders. Can J Psychiatry. 2025:7067437251374564. doi:10.1177/07067437251374564.